STEL Q1 2026 Earnings Strong EPS Beat Amid Marginal Stock Decline Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares VICR Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed DORM Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline LMFA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Company Posts Zero Revenue